Compounded semaglutide has no FDA-approved dosing schedule. This chart uses labeled Wegovy injection doses as a reference, including 1.7 or 2.4 mg weekly maintenance for adult weight reduction; it does not establish a schedule for a compounded prescription. The units depend on the vial's concentration. At 2.5 mg/mL, 0.25 mg is 10 units on a U-100 syringe; at 5 mg/mL it is 5 units. Your prescriber and pharmacy set the actual dose and strength.[1] For a service that names the pharmacies filling its prescriptions, the SnagRx review lists compounded semaglutide at $99 a month on a month-to-month plan.
Injectable and oral semaglutide have different schedules. Wegovy tablets have a separate daily regimen; the weekly injection chart below does not apply to tablets. The label also includes Wegovy HD 7.2 mg for selected adults, which is not a compounded-vial instruction.[1] The FDA has documented errors when patients measure compounded injections from vials.[5] These concentration examples help explain a prescription; your prescriber and pharmacy must confirm the dose, vial strength and syringe instructions.
What is the standard semaglutide titration schedule?
The table shows the Wegovy injection label schedule for reference. Each step lasts four weeks, and the dose climbs slowly to reduce nausea and other stomach side effects. For weight reduction in adults, the label allows a maintenance dose of 1.7 mg or 2.4 mg, with 2.4 mg recommended.[1] The current label (revised June 2026) also allows 7.2 mg weekly (Wegovy HD) after at least four weeks tolerating 2.4 mg when more weight reduction is clinically indicated.[1] This is a branded injection option, not a recommendation to increase a compounded dose. The vial-conversion examples below stop at 2.4 mg.
Swipe to see all columns
| Weeks | Weekly dose (Wegovy label) | Purpose |
|---|---|---|
| 1–4 | 0.25 mg | Starting dose |
| 5–8 | 0.5 mg | Escalation |
| 9–12 | 1 mg | Escalation |
| 13–16 | 1.7 mg | Escalation |
| 17 onward | 2.4 mg (recommended) or 1.7 mg | Maintenance |
| After ≥4 weeks at 2.4 mg, if needed | 7.2 mg (branded Wegovy HD) | Optional higher maintenance |
Two notes on this schedule. The 0.25, 0.5 and 1 mg steps are for getting used to the drug; the label does not treat them as maintenance doses for weight loss. And the four-week pace is a minimum, not a deadline. If a dose is not tolerated, the label says to consider delaying the next step by four weeks.[1] Our GLP-1 dose ladder tool shows the branded schedules for Wegovy, Ozempic, Zepbound and Mounjaro side by side.
How many units is each dose at 1, 2.5 and 5 mg/mL?
The rule is simple: divide the dose in milligrams by the vial's concentration in mg/mL to get milliliters, then multiply by 100 to get units on a U-100 insulin syringe. For example, 0.25 mg ÷ 2.5 mg/mL = 0.1 mL = 10 units. The chart below illustrates that arithmetic. These are example concentrations, not a list of standard compounded strengths or instructions to select a dose.
Swipe to see all columns
| Weekly dose | 1 mg/mL vial | 2.5 mg/mL vial | 5 mg/mL vial |
|---|---|---|---|
| 0.25 mg | 0.25 mL = 25 units | 0.10 mL = 10 units | 0.05 mL = 5 units |
| 0.5 mg | 0.50 mL = 50 units | 0.20 mL = 20 units | 0.10 mL = 10 units |
| 1 mg | 1.00 mL = 100 units | 0.40 mL = 40 units | 0.20 mL = 20 units |
| 1.7 mg | 1.70 mL = 170 units* | 0.68 mL = 68 units | 0.34 mL = 34 units |
| 2.4 mg | 2.40 mL = 240 units* | 0.96 mL = 96 units | 0.48 mL = 48 units |
Notice that at 5 mg/mL the starting dose is just 5 units, a very small mark on a 100-unit syringe. That is why the syringe size matters (see below). If your vial strength or preparation instructions are unclear, contact the dispensing pharmacy before measuring a dose.
Why do compounded vials differ, and what dosing errors has the FDA seen?
Compounded semaglutide is not FDA-approved, and there is no single standard product. Each compounding pharmacy chooses its own concentration, vial size and sometimes added ingredients. Compounding was widely allowed while semaglutide was in shortage. The FDA declared that shortage resolved on February 21, 2025, and its grace period for compounders ended in April 2025 for 503A pharmacies and May 2025 for 503B outsourcing facilities.[6] In February 2026 the FDA said it intends to act against mass-marketed, non-approved GLP-1 drugs.[7] Our compounded vs branded GLP-1 guide explains where that leaves patients.
The FDA's July 2024 alert describes two kinds of error. Some patients drawing their own doses took 5 to 20 times the intended amount. Some clinicians miscalculated unit conversions, leading to doses 5 to 10 times too high. In one pattern, patients told to inject 5 units drew 50 units instead. Reported effects included stomach and bowel symptoms, fainting, headache, dehydration, acute pancreatitis and gallstones, and some patients were hospitalized.[5]
How do I read a U-100 insulin syringe?
A U-100 syringe is marked in units, where 100 units equals 1 mL. They come in three common sizes: 0.3 mL (30 units), 0.5 mL (50 units) and 1 mL (100 units). On many 0.3 mL and 0.5 mL syringes each line is 1 unit, which makes a 5- or 10-unit dose easier to see. On a 1 mL syringe each line is often 2 units. Read the dose at the edge of the plunger's stopper nearest the needle. Remove air bubbles before you check the line. Our step-by-step semaglutide injection guide covers technique, sites and needle disposal.
What if I miss a dose or need to step back down?
The following rules belong to the Wegovy injection label, not to every compounded prescription. If you miss one dose and the next scheduled dose is more than 2 days away, take it as soon as you can. If the next dose is less than 2 days away, skip the missed dose and take the next one on schedule. If you miss two or more doses in a row, the label says to restart titration at a lower dose to reduce the risk of stomach side effects.[1] How much lower is a decision for your prescriber. For a compounded prescription, ask the prescriber how to handle missed doses or restart; do not use this branded-label summary to choose your own restart dose. If a step causes side effects you cannot manage, the label suggests waiting four more weeks before moving up.[1] Some people take lower doses on purpose for longer; our GLP-1 microdosing review covers what is known about that.
How does branded Wegovy maintenance differ from compounded treatment?
Compounded semaglutide has no FDA-approved maintenance schedule. Use the dose on your prescription and confirm it with your prescriber or pharmacy if anything is unclear.
For adult weight reduction, the branded Wegovy injection label lists 1.7 mg or 2.4 mg once weekly, with 2.4 mg recommended. The label allows a higher 7.2 mg Wegovy HD dose only after at least four weeks tolerating 2.4 mg and when additional weight reduction is clinically indicated. Wegovy tablets follow a separate daily schedule.[1]The STEP trials summarized here studied 2.4 mg. In STEP 1, 1,961 adults without diabetes took 2.4 mg weekly or placebo for 68 weeks. Mean weight change was −14.9% versus −2.4% (difference −12.4 percentage points; 95% CI −13.4 to −11.5).[2]
Staying on the dose matters. In STEP 4, people who reached 2.4 mg and kept taking it lost a further 7.9% over 48 weeks, while those switched to placebo regained 6.9%.[3] In the STEP 1 extension, people who stopped regained about two-thirds of the weight they had lost within a year.[4] For how long results take to show, see our semaglutide results timeline; for choosing between 1.7 and 2.4 mg, see GLP-1 maintenance dose. For the tirzepatide version of this chart, see the compounded tirzepatide dosage chart.
Where do providers we review sell compounded semaglutide, and at what price?
Prices change often, and many providers charge more as the dose rises. We list current prices, read from each company's public website, on two pages. The semaglutide provider list compares services on care model, transparency and price, with partners listed first. The semaglutide price comparison ranks offers with matching payment terms and leaves unmatched prices unranked. When you compare, ask what the price is at your dose, not just the starting dose, and which pharmacy compounds the vial. For pharmacy-direct options, see compounding pharmacy semaglutide.
The bottom line
Compounded semaglutide has no FDA-approved dose schedule. Wegovy injection dosing provides context, but your prescriber and pharmacy must set your compounded instructions. The number of U-100 syringe units depends on both the prescribed milligrams and your vial's concentration, and that is where the documented errors happen. Treat this chart as a way to check your instructions, not to replace them. If the units on your syringe do not match the arithmetic for your dose and vial, stop and call your pharmacy before you inject.